MedPath

A CLINICAL STUDY OF VASA KSHARASUTRA IN THE MANAGEMENT OF FISTULA-IN-ANO

Phase 4
Completed
Conditions
Anal fistula,
Registration Number
CTRI/2019/06/019828
Lead Sponsor
NAtional Institute of Ayurveda
Brief Summary

Objectives

a.       To evaluate the efficacy of *Vasa Ká¹£arasutra* in the management of  *Bhagandara*(Fistula-in-Ano).

 b.      To compare the efficacy of *Vasa Ká¹£arasutra* with conventional *Apamarga Ká¹£arasutra* in the management of *Bhagandara*(Fistula-in-Ano).

Results and conclusions

v *Bhagandara*(Fistula-in-ano) is a disease which was mentioned since the time of *Vedas* and *Purana*.

v*Ksharasutra* treatment is the most suitable and effective modality in the treatment of *Bhagandara*.

v *Ksharasutra* method can be known as a treatment which is safe, effective with minimum or no recurrence.

v The people suffering from constipation, *Mandagni*, having irregular dietary habits, are prone to this disease and the incidence of *Bhagandara* (Fistula-in-ano) is more in males as compared to females.

v The prevalence of *Bhagandara* is more in the middle age group with who does not have proper hygiene.

v Both types of *Ksharasutras* are cost effective and easily applicable.

v Both types were found to be very much effective in reduction of discharge, pain, itching, burning sensation, tenderness and oedema. Inter group compression showed there was no difference between the groups.

v *Vasa Ksharasutra* is having significant less UCT when compared with the *Apamarga Ksharasutra*.

v Both the variety shows less recurrences.

v Necrosis, anal incontinence and stenosis were not reported in either group.

v Finally we can conclude *Vasa Ksharasutra is* an alternative for *Apamarga Ksharasutra* and by comparing UCT can decide it’s having much better action than *Apamarga Ksharasutra.*

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
30
Inclusion Criteria
  • 1.Male or female between age 20 to 60 years and willing to give their written Informed consent.
  • 2.No major systemic disease involved.
  • Patients who have signs and symptoms of Bhagandara (Fistula-in-ano).
Exclusion Criteria
  • Bhagandara (Fistula-in-ano) associated with one or more of the following conditions:- Ulcerative Colitis Uncontrolled Hypertension Uncontrolled Diabetes Mellitus Veneral diseases HIV and Hepatitis B patients Crohn’s disease Fistula other than ano-rectal area.
  • All other secondary Fistulae-in-ano.

Study & Design

Study Type
PMS
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in the Unit Cutting Time (UCT) of the Fistulous Tract90 days
Secondary Outcome Measures
NameTimeMethod
Reduction in pain, itching and amount of discharge of the Fistulous Tract.90 Days

Trial Locations

Locations (1)

National Institute of Ayurveda

🇮🇳

Jaipur, RAJASTHAN, India

National Institute of Ayurveda
🇮🇳Jaipur, RAJASTHAN, India
Dr Anura Wicramanayake
Principal investigator
6375128531
dr.anurawaap@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.